PRMTs and miRNAs: functional cooperation in cancer and beyond

References

• Blanc RS, Richard S. Arginine methylation: the coming of age. Mol Cell. 2017;65(1):8–24.
   PubMed Web of Science ®Google Scholar
• Wei H, Mundade R, Lange K, et al. Protein arginine methylation of non-histone proteins and its role in diseases. Cell Cycle. 2014;13(1):32–41.
   PubMed Web of Science ®Google Scholar
• Prabhu L, Wei H, Chen L, et al. Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers. Oncotarget. 2017;8(25):39963–39977.
   PubMedGoogle Scholar
• Wei H, Wang B, Miyagi M, et al. PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB. Proc Natl Acad Sci U S A. 2013;110(33):13516–13521.
   PubMed Web of Science ®Google Scholar
• Bachand F. Protein arginine methyltransferases: from unicellular eukaryotes to humans. Eukaryot Cell. 2007;6(6):889–898.
   PubMedGoogle Scholar
• Cook JR, Lee J-H, Yang Z-H, et al. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues. Biochem Biophys Res Commun. 2006;342(2):472–481.
   PubMed Web of Science ®Google Scholar
• Lee S-H, Chen T-Y, Dhar SS, et al. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness. Nucleic Acids Res. 2016;44(22):10603–10618.
   PubMed Web of Science ®Google Scholar
• Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell. 2009;33(1):1–13.
   PubMed Web of Science ®Google Scholar
• Stouth DW, vanLieshout TL, Shen NY, et al. Regulation of skeletal muscle plasticity by protein arginine methyltransferases and their potential roles in neuromuscular disorders. Front Physiol. 2017;8:870.
   PubMed Web of Science ®Google Scholar
• Baldwin RM, Morettin A, Cote J. Role of PRMTs in cancer: could minor isoforms be leaving a mark? World J Biol Chem. 2014;5(2):115–129.
   PubMedGoogle Scholar
• Yang Y, Bedford MT. Protein arginine methyltransferases and cancer. Nat Rev Cancer. 2013;13(1):37–50.
   PubMed Web of Science ®Google Scholar
• Romano G, Veneziano D, Acunzo M, et al. Small non-coding RNA and cancer. Carcinogenesis. 2017;38(5):485–491.
   PubMed Web of Science ®Google Scholar
• Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20(8):460–469.
   PubMed Web of Science ®Google Scholar
• Tang J, Ahmad A, Sarkar FH. The role of microRNAs in breast cancer migration, invasion and metastasis. Int J Mol Sci. 2012;13(10):13414–13437.
   PubMed Web of Science ®Google Scholar
• Lynam-Lennon N, Maher SG, Reynolds JV. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc. 2009;84(1):55–71.
   PubMed Web of Science ®Google Scholar
• Iorio MV, Piovan C, Croce CM. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta. 2010;1799(10–12):694–701.
   PubMed Web of Science ®Google Scholar
• Datta J, Kutay H, Nasser MW, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 2008;68(13):5049–5058.
   PubMed Web of Science ®Google Scholar
• Tarighat SS, Santhanam R, Frankhouser D, et al. The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation. Leukemia. 2016;30(4):789–799.
   PubMed Web of Science ®Google Scholar
• Bueno MJ, Pérez de Castro I, Gómez de Cedrón M, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 2008;13(6):496–506.
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhou J, Xu F, et al. Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia. J Clin Invest. 2016;126(10):3961–3980.
   PubMed Web of Science ®Google Scholar
• Vu LP, Perna F, Wang L, et al. PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complex. Cell Rep. 2013;5(6):1625–1638.
   PubMed Web of Science ®Google Scholar
• Yang CH, Pfeffer SR, Sims M, et al. The oncogenic microRNA-21 inhibits the tumor suppressive activity of FBXO11 to promote tumorigenesis. J Biol Chem. 2015;290(10):6037–6046.
   PubMed Web of Science ®Google Scholar
• Hunter SE, Finnegan EF, Zisoulis DG, et al. Functional genomic analysis of the let-7 regulatory network in Caenorhabditis elegans. PLoS Genet. 2013;9(3):e1003353.
   PubMed Web of Science ®Google Scholar
• Zhang G, Hussain M, Asgari S. Regulation of arginine methyltransferase 3 by a Wolbachia-induced microRNA in Aedes aegypti and its effect on Wolbachia and dengue virus replication. Insect Biochem Mol Biol. 2014;53:81–88.
   PubMed Web of Science ®Google Scholar
• Wu Z, Li H, Rao L, et al. Derivation and characterization of human embryonic stem cell lines from the Chinese population. J Genet Genomics. 2011;38(1):13–20.
   PubMed Web of Science ®Google Scholar
• Chen T-Y, Lee S-H, Dhar SS, et al. Protein arginine methyltransferase 7-mediated microRNA-221 repression maintains Oct4, Nanog, and Sox2 levels in mouse embryonic stem cells. J Biol Chem. 2018;293(11):3925–3936.
   PubMed Web of Science ®Google Scholar
• Jing P, Zhao N, Ye M, et al. Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling. Cancer Lett. 2018;427:38–48.
   PubMed Web of Science ®Google Scholar
• Spadotto V,  Giambruno R, Massignani E, et al. PRMT1-mediated methylation of the Large Drosha Complex regulates microRNA biogenesis. BioRxiv. [Preprint]. November 9, 2018 [cited 2019 Feb 5]. doi:10.1101/466813
   Google Scholar
• Alinari L, Mahasenan KV, Yan F, et al. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood. 2015;125(16):2530–2543.
   PubMed Web of Science ®Google Scholar
• Pal S, Baiocchi RA, Byrd JC, et al. Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma. Embo J. 2007;26(15):3558–3569.
   PubMed Web of Science ®Google Scholar
• Wang L, Pal S, Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol. 2008;28(20):6262–6277.
   PubMed Web of Science ®Google Scholar
• Lu Y-F, Cai X-L, Li -Z-Z, et al. LncRNA SNHG16 functions as an oncogene by sponging MiR-4518 and up-regulating PRMT5 expression in Glioma. Cell Physiol Biochem. 2018;45(5):1975–1985.
   PubMedGoogle Scholar
• Zhang H, Guo X, Feng X, et al. MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein. Oncotarget. 2017;8(2):2342–2355.
   PubMedGoogle Scholar
• Xue J, Chi Y, Chen Y, et al. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity. Oncogene. 2016;35(4):448–458.
   PubMed Web of Science ®Google Scholar
• Ma Y, Deng F, Li P, et al. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells. Biomed Pharmacother. 2018;101:648–655.
   PubMed Web of Science ®Google Scholar
• Li B, Liu L, Li X, et al. miR-503 suppresses metastasis of hepatocellular carcinoma cell by targeting PRMT1. Biochem Biophys Res Commun. 2015;464(4):982–987.
   PubMed Web of Science ®Google Scholar
• Zhang M, Wu W, Gao M, et al. Coactivator-associated arginine methyltransferase 1 promotes cell growth and is targeted by microRNA-195-5p in human colorectal cancer. Tumour Biol. 2017;39(3):1010428317694305.
   Google Scholar
• Zheng L, Chen J, Zhou Z, et al. miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1. Onco Targets Ther. 2017;10:1027–1038.
   PubMed Web of Science ®Google Scholar
• Zhou -S-S, Jin J-P, Wang J-Q, et al. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges. Acta Pharmacol Sin. 2018;39(7):1073–1084.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang L, Li H, et al. Coactivator-associated arginine methyltransferase 1 targeted by miR-15a regulates inflammation in acute coronary syndrome. Atherosclerosis. 2014;233(2):349–356.
   PubMed Web of Science ®Google Scholar
• Selvi BR, Swaminathan A, Maheshwari U, et al. CARM1 regulates astroglial lineage through transcriptional regulation of Nanog and posttranscriptional regulation by miR92a. Mol Biol Cell. 2015;26(2):316–326.
   PubMed Web of Science ®Google Scholar
• Baulina N, Kulakova O,Favorova O. MicroRNAs: the role in autoimmune inflammation. Acta Naturae. 2016;8(1):21–33.
   PubMed Web of Science ®Google Scholar
• Sun Q, Liu L, Wang H, et al. Constitutive high expression of protein arginine methyltransferase 1 in asthmatic airway smooth muscle cells is caused by reduced microRNA-19a expression and leads to enhanced remodeling. J Allergy Clin Immunol. 2017;140(2):510–524.e3.
   Web of Science ®Google Scholar
• Xu Z, Jiang J, Xu C, et al. MicroRNA-181 regulates CARM1 and histone aginine methylation to promote differentiation of human embryonic stem cells. PLoS One. 2013;8(1):e53146.
   PubMed Web of Science ®Google Scholar
• Mallappa C, Hu Y-J, Shamulailatpam P, et al. The expression of myogenic microRNAs indirectly requires protein arginine methyltransferase (Prmt)5 but directly requires Prmt4. Nucleic Acids Res. 2011;39(4):1243–1255.
   PubMed Web of Science ®Google Scholar